Claims for Patent: 7,112,721

Summary for Patent: 7,112,721

Title:	Methods and constructs for plant transformation
Abstract:	The present invention relates to novel methods for the transformation of crop species, novel methods for the selection and identification of transformed plant cells and novel methods for recovery of regenerated whole plants. The method also relates to the development of plants with novel traits and plants that contain novel recombinant DNA constructs.
Inventor(s):	Fabijanski; Steven F. (Ottawa, CA), Robert; Laurian (Gatineau, CA), Schernthaner; Johann (Orleans, CA), Wu; Tong (Gatineau, CA)
Assignee:	Sakata Seed Corporation (Yokohama, JP)
Application Number:	10/182,616
Patent Claims:	1. A method for preparing a transformed plant, comprising: (a) introducing into plant cells a construct comprising, in the 5' to 3' direction: a right Agrobacterium T-DNA border sequence; a T-DNA oncogenic region of an Agrobacterium Ti-plasmid, said T-DNA oncogenic region comprising the full complement of oncogenes found in wild-type Agrobacterium T-DNA; a left Agrobacterium T-DNA border sequence; and first and second recombinase recognition sites intermediate to said right and left T-DNA border sequences; said construct further comprising a recombinase coding sequence encoding a recombinase that recognizes said first and second recombinase recognition sites, said recombinase coding sequence being under the control of an inducible promoter; to obtain transformed cells comprising said construct; the presence of said T-DNA oncogenic region in said transformed cells resulting in tumor formation; (b) culturing said transformed cells under conditions that are insufficient for the growth of untransformed cells and that are sufficient for said transformed cells to form tumor tissue, whereby transformed cells are selected; and (c) negating the effect of said T-DNA oncogenic region in said transformed cells by excising at least a portion of said T-DNA oncogenic region with said recombinase; and regenerating morphologically normal transformed plants from said transformed cells. 2. The method according to claim 1, wherein at least one of said first and second recombinase recognition sites is within said T-DNA oncogenic region. 3. The method according to claim 1, wherein neither of said first and second recombinase recognition sites is within said T-DNA oncogenic region. 4. The method according to claim 1, wherein said construct further comprises a novel trait coding sequence located either 5' to said first recombinase recognition site or 3' to said second recombinase recognition site, the expression of said novel coding sequence in a plant conferring a novel trait on said plant. 5. The method according to claim 1 wherein said recombinase coding sequence includes a plant intron. 6. The method according to claim 1 wherein said recombinase is selected from the group consisting of FLP recombinase, Cre recombinase, and R recombinase. 7. The method according to claim 1, wherein said plant cells are dicot cells. 8. The method according to claim 7, wherein said plant cells are cells of a member of the family Malvaceae, Linaceae, Compositae, Solanacae, Fabaceae, Euphorbiaceae, Oleaceae, or Brassicaceae. 9. The method according to claim 7, wherein said plant cells are cells of a member of the genus Brassica. 10. The method according to claim 7, wherein said plant cells are cells of broccoli, cabbage, cauliflower, kale, Chinese kale, collard, kohlrabi, Chinese cabbage, pak choi, or turnip. 11. The method according to claim 1, wherein said construct is introduced into said plant cell by Agrobacterium-mediated transformation.

Details for Patent 7,112,721

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2020-02-08
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2020-02-08
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2020-02-08